# Top Remote Immunotherapy Companies

Himalayas lists 26 companies for this search, most open remote jobs first.

Source: https://himalayas.app/companies/markets/immunotherapy

## Top Remote Immunotherapy Companies

| Company | Summary | Open remote jobs | Employees |
| --- | --- | --- | --- |
| [Regeneron](https://himalayas.app/companies/regeneron.md) | Regeneron Pharmaceuticals is a leading biotechnology company dedicated to innovating life-changing medicines for serious diseases through proprietary scientific technologies. | 32 | 5000+ |
| [Therakos](https://himalayas.app/companies/therakos.md) | Therakos is a global leader in extracorporeal photopheresis (ECP) technology, providing innovative immunotherapy solutions for over 35 years. The company manufactures the THERAKOS CELLEX Photopheresis System used to treat Cutaneous T-Cell Lymphoma and other conditions at treatment centers worldwide. | 5 | 51-200 |
| [Immunome, Inc.](https://himalayas.app/companies/immunome-inc.md) | Immunome is a clinical-stage targeted oncology company developing first-in-class and best-in-class cancer therapies, including antibody-drug conjugates and radioligand therapies. | 4 | 51-200 |
| [Systimmune](https://himalayas.app/companies/systimmune.md) | SystImmune is a clinical-stage biopharmaceutical company focused on developing innovative antibody-drug conjugates (ADCs) and multi-specific antibodies for cancer treatment. | 2 | 51-200 |
| [Shennon Biotechnologies](https://himalayas.app/companies/shennon-biotechnologies.md) | ShennonBio is a precision immunotherapy company developing T-cell engagers for solid tumors using its proprietary TCELERATOR platform that enables ultra-high-throughput single-cell functional screening combined with computational engineering. | 1 | 11-50 |
| [United Allergy Services](https://himalayas.app/companies/united-allergy-services.md) | United Allergy Services partners with healthcare providers to deliver in-office allergy testing and customized immunotherapy treatments, empowering primary care practices to offer comprehensive allergy care. | 1 | 501-1000 |
| [Umoja Biopharma](https://himalayas.app/companies/umoja-biopharma.md) | Umoja Biopharma is a clinical-stage biotechnology company dedicated to developing integrated, in vivo immunotherapy technologies to democratize access to CAR T cell cancer treatments. | 1 | 51-200 |
| [Genmab](https://himalayas.app/companies/genmab.md) | Genmab A/S is an innovative biotechnology company focused on developing antibody therapeutics to improve patient care, particularly in oncology. | 1 | 1001-5000 |
| [Aura Biosciences](https://himalayas.app/companies/aura-biosciences.md) | Aura Biosciences is a clinical-stage biotechnology company developing virus-like drug conjugates for solid tumors, with lead candidate bel-sar in late-stage trials for ocular cancers including choroidal melanoma. | 0 | 51-200 |
| [Bicara Therapeutics, Inc.](https://himalayas.app/companies/bicara-therapeutics-inc.md) | Bicara Therapeutics is a clinical-stage oncology biotechnology company pioneering first-in-class bifunctional antibodies that combine targeted therapy with immunotherapy for the treatment of solid tumors. | 0 | 51-200 |
| [Cartography Biosciences](https://himalayas.app/companies/cartography-biosciences.md) | Cartography Biosciences is a South San Francisco-based biotechnology company developing precision oncology therapies using AI-powered discovery platforms to identify tumor-selective targets for antibody-based cancer treatments. | 0 | 51-200 |
| [Elicio Therapeutics](https://himalayas.app/companies/elicio-therapeutics.md) | Clinical-stage biotechnology company developing novel lymph node-targeted cancer immunotherapies using its proprietary Amphiphile (AMP) platform, with lead program ELI-002 targeting KRAS-driven cancers. | 0 | 11-50 |
| [MacroGenics](https://himalayas.app/companies/macrogenics.md) | MacroGenics is a clinical-stage biopharmaceutical company developing next-generation antibody-based therapies for cancer treatment, with FDA-approved therapeutics and a diverse pipeline of novel candidates. | 0 | 201-500 |
| [CatalYm GmbH](https://himalayas.app/companies/catalym-gmbh.md) | CatalYm is a biotechnology company developing visugromab, an antibody targeting GDF-15, to overcome cancer therapy resistance and support immune-based anti-tumor responses. The company is advancing visugromab through clinical development in solid tumors. | 0 | 11-50 |
| [Artiva Biotherapeutics](https://himalayas.app/companies/artiva-biotherapeutics.md) | Artiva Biotherapeutics is a clinical-stage biotech company developing off-the-shelf, allogeneic NK cell therapies for autoimmune diseases, with its lead candidate AlloNK® in clinical trials. | 0 | 51-200 |
| [Modena Allergy & Asthma](https://himalayas.app/companies/modena-allergy-asthma.md) | Modena Allergy + Asthma is a leading allergy, asthma, and immunology practice with multiple locations across Southern California and Arizona, founded by Dr. Brian Modena in 2022. | 0 | 51-200 |
| [The Wistar Institute](https://himalayas.app/companies/the-wistar-institute.md) | The Wistar Institute is the nation's first independent nonprofit biomedical research institution, founded in 1892, specializing in cancer, immunology, infectious disease, and vaccine development. | 0 | 201-500 |
| [Candel Therapeutics](https://himalayas.app/companies/candeltx.md) | A clinical-stage biopharmaceutical company developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. | 0 | 51-200 |
| [Fate Therapeutics](https://himalayas.app/companies/fate-therapeutics.md) | Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing first-in-class cellular immunotherapies for cancer and immune disorders, utilizing its proprietary induced pluripotent stem cell (iPSC) product platform. | 0 | 201-500 |
| [Parallel Bio](https://himalayas.app/companies/parallel-bio.md) | Parallel Bio is a biotech company focused on using the human immune system and AI to develop drugs more effectively and ethically. | 0 | 51-200 |

Page 1 of 2. Next page: [page 2](https://himalayas.app/companies/markets/immunotherapy.md?page=2)
